Curaleaf Holdings (CURLF) Change in Cash (2019 - 2024)
Curaleaf Holdings (CURLF) posted quarterly Change in Cash of $15.4 million for Q4 2024, up 164.45% year-on-year from $5.8 million in Q1 2024, and up 531.2% on a QoQ basis from $2.4 million in Q3 2024.
Curaleaf Holdings (CURLF) Change in Cash (2019 - 2024) Analysis & Trends
Curaleaf Holdings (CURLF) has reported Change in Cash for 6 consecutive years, with $15.4 million the latest figure, recorded in Q4 2024.
- Quarterly Change in Cash rose 164.45% year-over-year to $15.4 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $15.6 million (up 122.08% YoY) and the FY2025 annual result came in at -$6.1 million, down 139.41% from the prior year.
- Change in Cash climbed to $15.4 million in Q4 2024 per CURLF's latest filing, from $2.4 million in the prior quarter.
- Over the last five years, Change in Cash for CURLF reached as high as $60.8 billion in Q1 2024 and fell as low as -$60.8 billion in Q2 2024.
- A 5-year average of $5.8 million and a median of -$2.1 million in 2020 frame the typical range for Change in Cash.
- The largest YoY upside for Change in Cash was 90231.44% in 2023 against a maximum downside of 84894.18% in 2023.
- Year by year, Change in Cash stood at -$4.1 million in 2020, then tumbled by 355.73% to -$18.7 million in 2021, then tumbled by 83.68% to -$34.4 million in 2022, then jumped by 30.52% to -$23.9 million in 2023, then soared by 164.45% to $15.4 million in 2024.
- According to Business Quant data, Change in Cash over the past three periods registered $15.4 million, $2.4 million, and -$60.8 billion for Q4 2024, Q3 2024, and Q2 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 185.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -509.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -388.85 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -277.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 457.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -117.00 Mn |
| 10 | Curaleaf Holdings | 7.13 Bn | 7.13 Bn | 157.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 15.40 Mn |
| Sep 30, 2024 | 2.44 Mn |
| Jun 30, 2024 | -60.76 Bn |
| Mar 31, 2024 | 60.76 Bn |
| Dec 31, 2023 | -23.89 Mn |
| Sep 30, 2023 | 31.71 Mn |
| Jun 30, 2023 | 47.40 Bn |
| Mar 31, 2023 | -47.48 Bn |
| Dec 31, 2022 | -34.38 Mn |
| Sep 30, 2022 | 11.16 Mn |
| Jun 30, 2022 | -52.59 Mn |
| Mar 31, 2022 | -55.87 Mn |
| Dec 31, 2021 | -18.72 Mn |
| Sep 30, 2021 | -14.60 Mn |
| Jun 30, 2021 | 19.13 Mn |
| Mar 31, 2021 | 241.05 Mn |
| Dec 31, 2020 | -4.11 Mn |
| Sep 30, 2020 | -37,025.00 |
| Jun 30, 2020 | -53.59 Mn |
| Mar 31, 2020 | 134.05 Mn |